CCL2 and depressive symptom measurement: In this study, the authors examined the associations of CSF dopaminergic biomarkers with depression severity (measured as Beck Depression Inventory [BDI-II] scores) and neuroinflammation (measured as a composite score of CSF concentrations of sCD14, MCP-1, IP-10, and neopterin) in a sample of HIV+ and HIV− participants [197].